Abbott downgraded at Argus on guidance cut

Abbott Laboratories (ABT) stock falls as Argus Research cut its 12-month rating on the MedTech giant to Hold from Buy citing its recent guidance cut. Read more here.

CryptoAlerta — análise de criptomoedas e mercado em tempo real